Brain Tumor Reports
54

Volume 17 Supplement 1
January 2017



Home > Publications > Brain Tumor Reports > Volume 17, Year 2017 > Supplement 1, January


CONTENTS



GLIOMAS
MEDULLOBLASTOMA





GLIOMAS



BRAIN STEM GLIOMAS


PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2016 May 18.
Source | Abstract | Full text | Similar articles




PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-2016 May 18.
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, Asgharzadeh S.
Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
Neuro Oncol. 2016 Jan;18(1):126-31. doi: 10.1093/neuonc/nov097. Epub 2015 Aug 8.
Source | Abstract | Full text | Similar articles




Cefalo G, Massimino M, Ruggiero A, Barone G, Ridola V, Spreafico F, Potepan P, Abate ME, Mascarin M, Garrè ML, Perilongo G, Madon E, Colosimo C, Riccardi R.
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
Neuro Oncol. 2014 May;16(5):748-53. doi: 10.1093/neuonc/not320. Epub 2014 Jan 30.
Source | Abstract | Full text | Similar articles




Dhall G.
Medulloblastoma.
J Child Neurol. 2009 Nov;24(11):1418-30. doi: 10.1177/0883073809341668 Epub 2009 Oct 19.
Source | Abstract | Full text | Similar articles




Grill J, Dufour C.
Neuro-oncology: Stability of medulloblastoma subgroups at tumour recurrence.
Nat Rev Neurol. 2014 Jan;10(1):5-6. doi: 10.1038/nrneurol.2013.256. Epub 2013 Dec 10.
Source | Abstract | Full text | Similar articles




Lafay-Cousin L, Smith A, Chi SN, Wells E, Madden J, Margol A, Ramaswamy V, Finlay J, Taylor MD, Dhall G, Strother D, Kieran MW, Foreman NK, Packer RJ, Bouffet E.
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.
Pediatr Blood Cancer. 2016 Sep;63(9):1527-34. doi: 10.1002/pbc.26042. Epub 2016 May 4. Erratum in: Pediatr Blood Cancer. 2017 Apr;64(4).
Source | Abstract | Full text | Similar articles




Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R.
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
J Clin Oncol. 2012 Sep 10;30(26):3187-93. doi: 10.1200/JCO.2011.39.8719. Epub 2012 Jul 30.
Source | Abstract | Full text | Similar articles




Massimino M, Biassoni V, Gandola L, Garrè ML, Gatta G, Giangaspero F, Poggi G, Rutkowski S.
Childhood medulloblastoma.
Crit Rev Oncol Hematol. 2016 Sep;105:35-51. doi: 10.1016/j.critrevonc.2016.05.012. Epub 2016 Jun 15.
Source | Abstract | Full text | Similar articles




Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S.
Childhood medulloblastoma.
Crit Rev Oncol Hematol. 2011 Jul;79(1):65-83. doi: 10.1016/j.critrevonc.2010.07.010. Epub 2010 Dec 3.
Source | Abstract | Full text | Similar articles




Massimino M, Casanova M, Polastri D, Biassoni V, Modena P, Pecori E, Schiavello E, De Pava MV, Indini A, Rampini P, Bauer D, Catania S, Podda M, Gandola L.
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Childs Nerv Syst. 2013 Jul;29(7):1107-12. doi: 10.1007/s00381-013-2104-x. Epub 2013 Apr 18.
Source | Abstract | Full text | Similar articles




Massimino M, Antonelli M, Gandola L, Miceli R, Pollo B, Biassoni V, Schiavello E, Buttarelli FR, Spreafico F, Collini P, Giangaspero F.
Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Pediatr Blood Cancer. 2013 Feb;60(2):210-6. doi: 10.1002/pbc.24225. Epub 2012 Jun 12.
Source | Abstract | Full text | Similar articles




Massimino M, Cefalo G, Riva D, Biassoni V, Spreafico F, Pecori E, Poggi G, Collini P, Pollo B, Valentini L, Potepan P, Seregni E, Casanova M, Ferrari A, Luksch R, Polastri D, Terenziani M, Pallotti F, Clerici CA, Schiavello E, Simonetti F, Meazza C, Catania S, Podda M, Gandola L.
Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
J Neurooncol. 2012 May;108(1):163-71. doi: 10.1007/s11060-012-0822-7. Epub 2012 Feb 16.
Source | Abstract | Full text | Similar articles




Millard NE, De Braganca KC.
Medulloblastoma.
J Child Neurol. 2016 Oct;31(12):1341-53. doi: 10.1177/0883073815600866. Epub 2015 Sep 2. Erratum in: J Child Neurol. 2016 Sep 15.
Source | Abstract | Full text | Similar articles




Pöschl J, Koch A, Schüller U.
Histological subtype of medulloblastoma frequently changes upon recurrence.
Acta Neuropathol. 2015 Mar;129(3):459-61. doi: 10.1007/s00401-015-1397-0. Epub 2015 Feb 8.
Source | Abstract | Full text | Similar articles




Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, André N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL.
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Acta Neuropathol. 2016 Jun;131(6):821-31. doi: 10.1007/s00401-016-1569-6. Epub 2016 Apr 4.
Source | Abstract | Full text | Similar articles




Ramaswamy V, Remke M, Bouffet E, Faria CC, Perreault S, Cho YJ, Shih DJ, Luu B, Dubuc AM, Northcott PA, Schüller U, Gururangan S, McLendon R, Bigner D, Fouladi M, Ligon KL, Pomeroy SL, Dunn S, Triscott J, Jabado N, Fontebasso A, Jones DT, Kool M, Karajannis MA, Gardner SL, Zagzag D, Nunes S, Pimentel J, Mora J, Lipp E, Walter AW, Ryzhova M, Zheludkova O, Kumirova E, Alshami J, Croul SE, Rutka JT, Hawkins C, Tabori U, Codispoti KE, Packer RJ, Pfister SM, Korshunov A, Taylor MD.
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Lancet Oncol. 2013 Nov;14(12):1200-7. doi: 10.1016/S1470-2045(13)70449-2. Epub 2013 Oct 17. Erratum in: Lancet Oncol. 2014 Apr;15(4):e154.
Source | Abstract | Full text | Similar articles




Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, Warmuth-Metz M, Clifford SC, Pietsch T, Pizer B, Lannering B; SIOP-E Brain Tumour Group.
Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.
J Neurooncol. 2016 Sep;129(3):515-24. doi: 10.1007/s11060-016-2202-1. Epub 2016 Jul 16.
Source | Abstract | Full text | Similar articles




Zollo M.
Genetics of recurrent medulloblastoma.
Lancet Oncol. 2013 Nov;14(12):1147-8. doi: 10.1016/S1470-2045(13)70482-0. Epub 2013 Oct 17.
Source | Abstract | Full text | Similar articles